{"completed suicide": 4.84, "drug interaction": 4.44, "extrapyramidal disorder": 45.44, "neuroleptic maligt syndrome": 38.82, "product use in unapproved indication": 2.19, "psychiatric symptom": 63.01, "psychotic disorder": 20.03, "restlessness": 6.79, "rhabdomyolysis": 6.89, "schizophrenia": 105.86, "suicidal ideation": 3.8, "weight increased": 7.85}